Bochao Danae Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bochao Danae Lin has a total of 187 co-authors. Here are the top co-authors by number of shared publications:
- Jurjen Justin Luykx
Amsterdam UMC Location University of Amsterdam, Psychiatry, Meibergdreef 9, Amsterdam, The Netherlands
11 shared publications - Bart P. F. Rutten
Department of Psychiatry and Neuropsychology, Mental Health and Neuroscience Research Institute, Maastricht University Medical Centre, Maastricht, The Netherlands
7 shared publications - Sinan Guloksuz
Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands
7 shared publications - Marco Pm Boks
Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands
4 shared publications - Angelo Arias-Magnasco
Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands
3 shared publications Bart P. F. Rutten
3 shared publications
Latest Publications
- Open Access
Latent Genetic Factors and Causal Pathways Linking Substance Use to Psychiatric and Personality Phenotypes: a Genomic SEM and Mendelian Randomization Study
Substance use and psychiatric disorders frequently co-occur, but establishing causality of their relationships is difficult given the multifactorial nature of these traits. To assess these relationships, we applied two genetically informed methods using the largest available European-ancestry genome-wide association studies of six substance use behaviors and twelve psychiatric and personality phenotypes. Using Genomic Structural Equation Modelling, we modelled the latent genetic architecture of the psychiatric and personality traits and examined these factors’ correlations with substance use traits. A structure with three factors fit the data best: F1 (PTSD, MDD, GAD, ADHD, agreeableness), F2 (BD, SCZ, OCD, openness), and F3 (OCD, GAD, extraversion, neuroticism), which showed differential correlations with substance use. Smoking correlated significantly which each factor, however, strongest with F1, alcohol use showed weak but significant correlations with F1 and F2, and cannabis use showed moderate correlations with F1 and F2, but strongest with F2. Using Mendelian Randomization, we examined bidirectional causal relationships. We found strong evidence that smoking continuation was causally associated with increased bipolar disorder risk, cigarettes per day with increased schizophrenia, and smoking initiation with increased extraversion and decreased agreeableness. Genetic liability to schizophrenia and PTSD were causally associated with increased risk of cannabis use, and schizophrenia with increased alcohol use. Liability to neuroticism, openness and agreeableness was causally linked to smoking behaviors, and extraversion to cannabis use. Most remaining associations showed weak causal evidence, largely due to heterogeneity and pleiotropy. Together, these findings provide evidence for both shared genetic liability and, for a subset of relationships, direct causal effects between substance use behaviors, psychiatric disorders, and personality traits, which can help inform future intervention and prevention research.
Open AccessLatent Genetic Factors and Causal Pathways Linking Substance Use to Psychiatric and Personality Phenotypes: a Genomic SEM and Mendelian Randomization Study
Substance use and psychiatric disorders frequently co-occur, but establishing causality of their relationships is difficult given the multifactorial nature of these traits. To assess these relationships, we applied two genetically informed methods using the largest available European-ancestry genome-wide association studies of six substance use behaviors and twelve psychiatric and personality phenotypes. Using Genomic Structural Equation Modelling, we modelled the latent genetic architecture of the psychiatric and personality traits and examined these factors’ correlations with substance use traits. A structure with three factors fit the data best: F1 (PTSD, MDD, GAD, ADHD, agreeableness), F2 (BD, SCZ, OCD, openness), and F3 (OCD, GAD, extraversion, neuroticism), which showed differential correlations with substance use. Smoking correlated significantly which each factor, however, strongest with F1, alcohol use showed weak but significant correlations with F1 and F2, and cannabis use showed moderate correlations with F1 and F2, but strongest with F2. Using Mendelian Randomization, we examined bidirectional causal relationships. We found strong evidence that smoking continuation was causally associated with increased bipolar disorder risk, cigarettes per day with increased schizophrenia, and smoking initiation with increased extraversion and decreased agreeableness. Genetic liability to schizophrenia and PTSD were causally associated with increased risk of cannabis use, and schizophrenia with increased alcohol use. Liability to neuroticism, openness and agreeableness was causally linked to smoking behaviors, and extraversion to cannabis use. Most remaining associations showed weak causal evidence, largely due to heterogeneity and pleiotropy. Together, these findings provide evidence for both shared genetic liability and, for a subset of relationships, direct causal effects between substance use behaviors, psychiatric disorders, and personality traits, which can help inform future intervention and prevention research.
- Open Access
- 25 September 2026
- Published by Center for Open Science in PsyArXiv
The Youth-GEMs project: genetic and environmental interactions underlying trajectories of youth mental health
Most mental disorders emerge before age 24, yet the mechanisms shaping youth mental health trajectories remain poorly understood. Here, we present the Youth-GEMs consortium performing a multidisciplinary, multisite research project funded by a European Union Horizon-Staying-Healthy-2021 grant. The Youth-GEMs project (Gene Environment interactions in Mental health trajectorieS of Youth) has an integrated, developmental framework that examines how genetic, epigenetic, and environmental factors dynamically interact to influence risk and resilience across adolescence and young adulthood. The project combines developmental (epi)genomic mapping of the human brain, genomic analyses of trans-syndromal phenotypes, exposome-wide environmental assessment, and Artificial Intelligence-based modelling to identify predictive and actionable markers of mental health trajectories of young people. By harmonizing multimodal data from existing population-based cohorts and by establishing the first international, trans-syndromal clinical cohort of help-seeking young people, Youth-GEMs is generating biologically informed polygenic and exposomic scores, cell-type-specific regulatory annotations, and interpretable machine-learning models. Continuous engagement with young people, clinicians, and stakeholders ensures that findings translate into tools for early detection, monitoring, and personalized intervention. Together, these efforts aim to advance mechanistic understandings of youth mental health, improve prediction of emerging illness, and support the development of evidence-based, developmentally sensitive approaches to prevention and care.
- 25 September 2026
- Published by Center for Open Science in PsyArXiv
Open AccessThe Youth-GEMs project: genetic and environmental interactions underlying trajectories of youth mental health
Most mental disorders emerge before age 24, yet the mechanisms shaping youth mental health trajectories remain poorly understood. Here, we present the Youth-GEMs consortium performing a multidisciplinary, multisite research project funded by a European Union Horizon-Staying-Healthy-2021 grant. The Youth-GEMs project (Gene Environment interactions in Mental health trajectorieS of Youth) has an integrated, developmental framework that examines how genetic, epigenetic, and environmental factors dynamically interact to influence risk and resilience across adolescence and young adulthood. The project combines developmental (epi)genomic mapping of the human brain, genomic analyses of trans-syndromal phenotypes, exposome-wide environmental assessment, and Artificial Intelligence-based modelling to identify predictive and actionable markers of mental health trajectories of young people. By harmonizing multimodal data from existing population-based cohorts and by establishing the first international, trans-syndromal clinical cohort of help-seeking young people, Youth-GEMs is generating biologically informed polygenic and exposomic scores, cell-type-specific regulatory annotations, and interpretable machine-learning models. Continuous engagement with young people, clinicians, and stakeholders ensures that findings translate into tools for early detection, monitoring, and personalized intervention. Together, these efforts aim to advance mechanistic understandings of youth mental health, improve prediction of emerging illness, and support the development of evidence-based, developmentally sensitive approaches to prevention and care.
- 6 May 2026
- Published by Springer Nature in Nature Mental Health
- Vol. 4 (5) , 766-774
Psychotropic medication use, lifestyle, genetic risk for high BMI and the incidence of cardiovascular disease
- 6 May 2026
- Published by Springer Nature in Nature Mental Health
- Vol. 4 (5) , 766-774
Psychotropic medication use, lifestyle, genetic risk for high BMI and the incidence of cardiovascular disease
- 19 May 2025
- Published by Springer Nature in Nature Mental Health
- Vol. 3 (6) , 613-625
Dissecting causal relationships between cortical morphology and neuropsychiatric disorders: a bidirectional Mendelian randomization study
Brain cortical morphology, indexed by its surface area and thickness, is known to be highly heritable. Previous research has suggested a relationship of cortical morphology with several neuropsychiatric phenotypes. However, the multitude of potential confounders makes it difficult to establish causal relationships. Here we employ generalized summary-data-based Mendelian randomization and a series of sensitivity analyses to investigate causal links between 70 cortical morphology measures and 199 neuropsychiatric, behavioral and metabolic phenotypes. We show that total brain cortical surface area (TSA) has significant positive causal effects on 18 phenotypes. The strongest effects include TSA positively influencing cognitive performance, while reverse analyses reveal small effects of cognitive performance on TSA. Global mean cortical thickness (MTH) exhibits significant causal effects on five phenotypes, including schizophrenia. MTH reduces schizophrenia risk, and bidirectional causality is found between MTH and smoking initiation. Finally, in regional analyses, we detect positive influences of the transverse temporal surface area on cognitive performance and negative influences of transverse temporal thickness on schizophrenia risk. Overall, our results highlight bidirectional associations between TSA, MTH and neuropsychiatric traits. These insights offer potential avenues for intervention studies aimed at improving brain health.
- 19 May 2025
- Published by Springer Nature in Nature Mental Health
- Vol. 3 (6) , 613-625
Dissecting causal relationships between cortical morphology and neuropsychiatric disorders: a bidirectional Mendelian randomization study
Brain cortical morphology, indexed by its surface area and thickness, is known to be highly heritable. Previous research has suggested a relationship of cortical morphology with several neuropsychiatric phenotypes. However, the multitude of potential confounders makes it difficult to establish causal relationships. Here we employ generalized summary-data-based Mendelian randomization and a series of sensitivity analyses to investigate causal links between 70 cortical morphology measures and 199 neuropsychiatric, behavioral and metabolic phenotypes. We show that total brain cortical surface area (TSA) has significant positive causal effects on 18 phenotypes. The strongest effects include TSA positively influencing cognitive performance, while reverse analyses reveal small effects of cognitive performance on TSA. Global mean cortical thickness (MTH) exhibits significant causal effects on five phenotypes, including schizophrenia. MTH reduces schizophrenia risk, and bidirectional causality is found between MTH and smoking initiation. Finally, in regional analyses, we detect positive influences of the transverse temporal surface area on cognitive performance and negative influences of transverse temporal thickness on schizophrenia risk. Overall, our results highlight bidirectional associations between TSA, MTH and neuropsychiatric traits. These insights offer potential avenues for intervention studies aimed at improving brain health.
- Open Access
Sex Differences in the Independent and Combined Effects of Genomic and Exposomic Risks for Schizophrenia on Distressing Psychotic Experiences: Insights from the ABCD Study
Purpose: To investigate sex-dependent effects of polygenic risk (PRS-SCZ) and exposome score (ES-SCZ) for schizophrenia, both independently and jointly, on distressing psychotic experiences (PEs) in early adolescents. Method: Baseline to 3-year follow-up data of the Adolescent Brain and Cognitive Development Study (ABCD) were used. PRS-SCZ and ES-SCZ were calculated to assess cumulative genetic and environmental (childhood adversity, cannabis use, hearing impairment, and winter births) risk for schizophrenia, respectively. The primary outcome was past-month distressing PEs at the 3-year follow-up. Secondary outcomes included distressing PEs across four yearly assessments: lifetime (≥1 wave), repeated (≥2 or ≥3 waves), and persisting (≥4 waves). Sex-stratified multilevel logistic regression models were used to test the independent and joint associations of binary modes (>75th percentile) of PRS-SCZ (PRS-SCZ 75 ) and ES-SCZ (ES-SCZ 75 ) on the outcomes. As sensitivity analysis, the sex-stratified analyses were repeated on a randomly selected unrelated sample, and the coefficients of males and females were compared. Results: PRS-SCZ 75 was not associated with past-month distressing PEs in either sex but significantly associated with lifetime and repeated (≥2 waves) distressing PEs only in females. However, a significant sex difference was only detected for lifetime distressing PEs. ES-SCZ 75 was significantly associated with past-month distressing PEs and all secondary outcomes without significant sex differences. No additive interaction between ES-SCZ 75 and PRS-SCZ 75 was detected for any PE outcomes. Conclusion: The influence of genomic risk for schizophrenia on distressing PEs might be sex-dependent, whereas that of the exposomic risk was universal in early adolescence. Further studies in larger samples are needed. Article Highlights: ▢ Genomic risks for schizophrenia were associated with distressing PEs only in female adolescents. ▢ Environmental risks for schizophrenia were associated with distressing PEs regardless of sex in early adolescence. ▢ Dose-response effects of the environmental risks on PE persistence support them as potential preventive targets. ▢ A sex-informed approach is needed to better understand genetic and environmental contributions to psychosis expression.
Open AccessSex Differences in the Independent and Combined Effects of Genomic and Exposomic Risks for Schizophrenia on Distressing Psychotic Experiences: Insights from the ABCD Study
Purpose: To investigate sex-dependent effects of polygenic risk (PRS-SCZ) and exposome score (ES-SCZ) for schizophrenia, both independently and jointly, on distressing psychotic experiences (PEs) in early adolescents. Method: Baseline to 3-year follow-up data of the Adolescent Brain and Cognitive Development Study (ABCD) were used. PRS-SCZ and ES-SCZ were calculated to assess cumulative genetic and environmental (childhood adversity, cannabis use, hearing impairment, and winter births) risk for schizophrenia, respectively. The primary outcome was past-month distressing PEs at the 3-year follow-up. Secondary outcomes included distressing PEs across four yearly assessments: lifetime (≥1 wave), repeated (≥2 or ≥3 waves), and persisting (≥4 waves). Sex-stratified multilevel logistic regression models were used to test the independent and joint associations of binary modes (>75th percentile) of PRS-SCZ (PRS-SCZ 75 ) and ES-SCZ (ES-SCZ 75 ) on the outcomes. As sensitivity analysis, the sex-stratified analyses were repeated on a randomly selected unrelated sample, and the coefficients of males and females were compared. Results: PRS-SCZ 75 was not associated with past-month distressing PEs in either sex but significantly associated with lifetime and repeated (≥2 waves) distressing PEs only in females. However, a significant sex difference was only detected for lifetime distressing PEs. ES-SCZ 75 was significantly associated with past-month distressing PEs and all secondary outcomes without significant sex differences. No additive interaction between ES-SCZ 75 and PRS-SCZ 75 was detected for any PE outcomes. Conclusion: The influence of genomic risk for schizophrenia on distressing PEs might be sex-dependent, whereas that of the exposomic risk was universal in early adolescence. Further studies in larger samples are needed. Article Highlights: ▢ Genomic risks for schizophrenia were associated with distressing PEs only in female adolescents. ▢ Environmental risks for schizophrenia were associated with distressing PEs regardless of sex in early adolescence. ▢ Dose-response effects of the environmental risks on PE persistence support them as potential preventive targets. ▢ A sex-informed approach is needed to better understand genetic and environmental contributions to psychosis expression.
- Open Access
Independent and joint effects of genomic and exposomic loads for schizophrenia on distressing and persisting psychotic experiences in adolescence
To assess the longitudinal associations of genomic and exposomic liabilities for schizophrenia, both independently and jointly, with distressing psychotic experiences (PEs) and their persistence in early adolescence. The Adolescent Brain and Cognitive Development Study data from children with European ancestry were used (n=5,122). The primary outcome was past-month distressing PEs at 3-year follow-up. Secondary outcomes were lifetime distressing PEs defined at varying cutoffs of persistence (from ≥ 1-4 waves). Multilevel logistic regression models were used to test the independent and joint associations of the binary modes (risk-category defined as above 75th percentile) of polygenic risk score for schizophrenia (PRS-SCZ 75 ) and exposome score for schizophrenia (ES-SCZ 75 ) on the outcomes. The relative excess risk due to interaction (RERI) was determined using the delta method to indicate departure additive interaction. PRS-SCZ 75 was statistically significantly associated with lifetime distressing PEs (≥ 1 wave) (OR 1.29 [95% CI 1.08, 1.53]) and repeating distressing PEs ≥ 2 waves (OR 1.34 [95% CI 1.08, 1.65]) but not with past-month distressing PEs or repeating distressing PEs at a higher cutoff of persistence. ES-SCZ 75 was consistently associated with past-month and repeating distressing PEs at all cutoffs, with increasing strength of association as a function of PEs persistence (one wave: OR 2.77 [95% CI 2.31, 3.31]; two waves: OR 3.16 [95% CI 2.54, 3.93]; three waves: OR 3.93 [95% CI 2.86, 5.40]; four waves: OR 3.65 [95% CI 2.34, 5.70]). There was evidence for additive interaction between ES-SCZ 75 and PRS-SCZ 75 for lifetime distressing PEs (RERI=1.26 95%CI: 0.14, 2.38), and repeating distressing PEs ≥ 2 waves (RERI=1.79, 95%CI: 0.35, 3.23). Genomic and exposomic liabilities for schizophrenia were independently and jointly associated with distressing PEs, as well as their persistence in early adolescence.
Open AccessIndependent and joint effects of genomic and exposomic loads for schizophrenia on distressing and persisting psychotic experiences in adolescence
To assess the longitudinal associations of genomic and exposomic liabilities for schizophrenia, both independently and jointly, with distressing psychotic experiences (PEs) and their persistence in early adolescence. The Adolescent Brain and Cognitive Development Study data from children with European ancestry were used (n=5,122). The primary outcome was past-month distressing PEs at 3-year follow-up. Secondary outcomes were lifetime distressing PEs defined at varying cutoffs of persistence (from ≥ 1-4 waves). Multilevel logistic regression models were used to test the independent and joint associations of the binary modes (risk-category defined as above 75th percentile) of polygenic risk score for schizophrenia (PRS-SCZ 75 ) and exposome score for schizophrenia (ES-SCZ 75 ) on the outcomes. The relative excess risk due to interaction (RERI) was determined using the delta method to indicate departure additive interaction. PRS-SCZ 75 was statistically significantly associated with lifetime distressing PEs (≥ 1 wave) (OR 1.29 [95% CI 1.08, 1.53]) and repeating distressing PEs ≥ 2 waves (OR 1.34 [95% CI 1.08, 1.65]) but not with past-month distressing PEs or repeating distressing PEs at a higher cutoff of persistence. ES-SCZ 75 was consistently associated with past-month and repeating distressing PEs at all cutoffs, with increasing strength of association as a function of PEs persistence (one wave: OR 2.77 [95% CI 2.31, 3.31]; two waves: OR 3.16 [95% CI 2.54, 3.93]; three waves: OR 3.93 [95% CI 2.86, 5.40]; four waves: OR 3.65 [95% CI 2.34, 5.70]). There was evidence for additive interaction between ES-SCZ 75 and PRS-SCZ 75 for lifetime distressing PEs (RERI=1.26 95%CI: 0.14, 2.38), and repeating distressing PEs ≥ 2 waves (RERI=1.79, 95%CI: 0.35, 3.23). Genomic and exposomic liabilities for schizophrenia were independently and jointly associated with distressing PEs, as well as their persistence in early adolescence.
- Open Access
Dissecting causal relationships between cortical morphology and neuropsychiatric disorders: a bidirectional Mendelian randomization study
Brain cortical morphology, indexed by its surface area and thickness, is known to be highly heritable. Previous research has suggested a relationship of cortical morphology with several neuropsychiatric phenotypes. However, the multitude of potential confounders makes it difficult to establish causal relationships. Here, we employ Generalized Summary-data-based Mendelian Randomization and a series of sensitivity analyses to investigate causal links between 70 cortical morphology measures and 199 neuropsychiatric, behavioral, and metabolic phenotypes. We show that total brain cortical surface area (TSA) has significant positive causal effects on 18 phenotypes. The strongest effects include TSA positively influencing cognitive performance, while reverse analyses reveal small effects of cognitive performance on TSA. Global mean cortical thickness (MTH) exhibits significant causal effects on five phenotypes, including schizophrenia. MTH reduces schizophrenia risk and bidirectional causality is found between MTH and smoking initiation. Finally, in regional analyses we detect positive influences of the transverse temporal surface area on cognitive performance and negative influences of transverse temporal thickness on schizophrenia risk. Overall, our results highlight bidirectional associations between TSA, MTH, and neuropsychiatric traits. These insights offer potential avenues for intervention studies aimed at improving brain health.
Open AccessDissecting causal relationships between cortical morphology and neuropsychiatric disorders: a bidirectional Mendelian randomization study
Brain cortical morphology, indexed by its surface area and thickness, is known to be highly heritable. Previous research has suggested a relationship of cortical morphology with several neuropsychiatric phenotypes. However, the multitude of potential confounders makes it difficult to establish causal relationships. Here, we employ Generalized Summary-data-based Mendelian Randomization and a series of sensitivity analyses to investigate causal links between 70 cortical morphology measures and 199 neuropsychiatric, behavioral, and metabolic phenotypes. We show that total brain cortical surface area (TSA) has significant positive causal effects on 18 phenotypes. The strongest effects include TSA positively influencing cognitive performance, while reverse analyses reveal small effects of cognitive performance on TSA. Global mean cortical thickness (MTH) exhibits significant causal effects on five phenotypes, including schizophrenia. MTH reduces schizophrenia risk and bidirectional causality is found between MTH and smoking initiation. Finally, in regional analyses we detect positive influences of the transverse temporal surface area on cognitive performance and negative influences of transverse temporal thickness on schizophrenia risk. Overall, our results highlight bidirectional associations between TSA, MTH, and neuropsychiatric traits. These insights offer potential avenues for intervention studies aimed at improving brain health.
- Open Access
Exposome-wide gene-environment interaction study of psychotic experiences in the UK Biobank
Background: A previous study successfully identified 148 out of 23,098 exposures associated with any psychotic experiences (PE) in the UK Biobank using an exposome-wide association study (XWAS). Research has shown that the polygenic risk score for schizophrenia (PRS-SCZ) is associated with PE. However, the interaction of these exposures and PRS-SCZ remains unknown. Method: To systematically investigate gene-environment interaction underlying PE through data-driven agnostic analyses, we conducted 1) a conditional XWAS adjusting for PRS-SCZ to estimate the main effects of the exposures and PRS-SCZ, respectively; 2) exposome-wide interaction studies (XWIS) to estimate multiplicative and additive interactions between PRS-SCZ and exposures; and 3) the correlations between PRS-SCZ and exposures. The study included 148,502 participants from UK biobank. Results: In the conditional XWAS models, the significant effects of PRS-SCZ and 148 exposures on PE remained statistically significant. In the XWIS model, we found a significant multiplicative (Ms, 1.23, 95%CI, 1.10-1.37; P=4.0×10 -4 ) and additive (RERI, 0.55; 95%CI, 0.32-0.77; SI, 0.22; 95%CI, 0.14-0.30; AP, 1.59; 95%CI, 1.30-1.91; all P < 0.05/148) interaction between PRS-SCZ and variable “serious medical conditions or disability” on PE. There were six additive gene-environment interactions identified for mental distress, help/treatment-seeking behaviors, vitamin D and sleep problems. In the correlation test focused on seven exposures with significant interaction with PRS-SCZ, no significant or small (r2< 0.04) gene-environment correlations were estimated. Conclusion: These findings reveal preliminary evidence for gene-environment interaction underlying PEs and suggest that genetic vulnerability and exposures might represent intertwined pathways leading to psychosis.
Open AccessExposome-wide gene-environment interaction study of psychotic experiences in the UK Biobank
Background: A previous study successfully identified 148 out of 23,098 exposures associated with any psychotic experiences (PE) in the UK Biobank using an exposome-wide association study (XWAS). Research has shown that the polygenic risk score for schizophrenia (PRS-SCZ) is associated with PE. However, the interaction of these exposures and PRS-SCZ remains unknown. Method: To systematically investigate gene-environment interaction underlying PE through data-driven agnostic analyses, we conducted 1) a conditional XWAS adjusting for PRS-SCZ to estimate the main effects of the exposures and PRS-SCZ, respectively; 2) exposome-wide interaction studies (XWIS) to estimate multiplicative and additive interactions between PRS-SCZ and exposures; and 3) the correlations between PRS-SCZ and exposures. The study included 148,502 participants from UK biobank. Results: In the conditional XWAS models, the significant effects of PRS-SCZ and 148 exposures on PE remained statistically significant. In the XWIS model, we found a significant multiplicative (Ms, 1.23, 95%CI, 1.10-1.37; P=4.0×10 -4 ) and additive (RERI, 0.55; 95%CI, 0.32-0.77; SI, 0.22; 95%CI, 0.14-0.30; AP, 1.59; 95%CI, 1.30-1.91; all P < 0.05/148) interaction between PRS-SCZ and variable “serious medical conditions or disability” on PE. There were six additive gene-environment interactions identified for mental distress, help/treatment-seeking behaviors, vitamin D and sleep problems. In the correlation test focused on seven exposures with significant interaction with PRS-SCZ, no significant or small (r2< 0.04) gene-environment correlations were estimated. Conclusion: These findings reveal preliminary evidence for gene-environment interaction underlying PEs and suggest that genetic vulnerability and exposures might represent intertwined pathways leading to psychosis.
- 23 September 2022
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 63, e193-e194
T47. INDEPENDENT REPLICATION AND DRUG-SPECIFICITY OF AN ANTIDEPRESSANT RESPONSE POLYGENIC RISK SCORE
- 23 September 2022
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 63, e193-e194
T47. INDEPENDENT REPLICATION AND DRUG-SPECIFICITY OF AN ANTIDEPRESSANT RESPONSE POLYGENIC RISK SCORE
- 23 September 2022
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 63, e237-e238
T129. CONVERGING EVIDENCE FOR POLYGENIC UNDERPINNINGS OF TREATMENT RESPONSE IN SEVERE MENTAL ILLNESS: FROM ELECTROCONVULSIVE THERAPY TO CLOZAPINE PHARMACOTHERAPY
- 23 September 2022
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 63, e237-e238
T129. CONVERGING EVIDENCE FOR POLYGENIC UNDERPINNINGS OF TREATMENT RESPONSE IN SEVERE MENTAL ILLNESS: FROM ELECTROCONVULSIVE THERAPY TO CLOZAPINE PHARMACOTHERAPY